Therefore, the aims of this study were to establish a recombinant plasmid vector bearing the HSVtk/GCV suicide system driven by a GFAP promoter to ablate GFAP-positive tumor cell lines selectively, and to characterize the possible neural differentiation of glioblastoma under GCV challenge. Here, GFAP is linked to glioblastoma.